Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Association of Naïve B Cells with Humoral Response to SARS-CoV-2 Vaccination

Eduard Schulz, Isabel Hodl, Patrick Forstner, Stefan Hatzl, Nazanin Sareban, Martina Moritz, Johannes Fessler, Barbara Dreo, Barbara Uhl, Claudia Url, Andrea Grisold, Michael Khalil, Barbara Kleinhappl, Christian Enzinger, Martin H. Stradner, Hildegard Greinix, Peter Schlenke, Ivo Steinmetz
doi: https://doi.org/10.1101/2021.08.11.21261898
Eduard Schulz
1Division of Haematology, Department of Internal Medicine, Medical University of Graz, Graz, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabel Hodl
2Division of Rheumatology and Immunology, Department of Internal Medicine, Medical University of Graz, Graz, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Forstner
3Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Graz, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefan Hatzl
1Division of Haematology, Department of Internal Medicine, Medical University of Graz, Graz, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nazanin Sareban
4Department of Blood Group Serology and Transfusion Medicine, Medical University of Graz, Graz, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martina Moritz
4Department of Blood Group Serology and Transfusion Medicine, Medical University of Graz, Graz, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johannes Fessler
5Institute of Immunology and Pathophysiology, Medical University of Graz, Graz, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara Dreo
2Division of Rheumatology and Immunology, Department of Internal Medicine, Medical University of Graz, Graz, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara Uhl
1Division of Haematology, Department of Internal Medicine, Medical University of Graz, Graz, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudia Url
4Department of Blood Group Serology and Transfusion Medicine, Medical University of Graz, Graz, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Grisold
3Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Graz, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Khalil
6Department of Neurology, Medical University of Graz, Graz, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara Kleinhappl
3Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Graz, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Enzinger
6Department of Neurology, Medical University of Graz, Graz, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin H. Stradner
2Division of Rheumatology and Immunology, Department of Internal Medicine, Medical University of Graz, Graz, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: martin.stradner@medunigraz.at
Hildegard Greinix
1Division of Haematology, Department of Internal Medicine, Medical University of Graz, Graz, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Schlenke
4Department of Blood Group Serology and Transfusion Medicine, Medical University of Graz, Graz, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ivo Steinmetz
3Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Graz, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Objectives Immunocompromised patients are at risk of severe coronavirus disease 2019 and are considered a high priority for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. Humoral vaccination response is impaired in these patients when circulating B cells are lacking. We aimed to analyze B-cell subsets at the time of vaccination to identify potential predictors of humoral vaccination response.

Methods Patients (n=120) receiving B-cell-depleting therapy (n=41), those suffering from inborn errors of immunity (n=25) and hematologic malignancies (n=56), and healthy controls (n=79) were vaccinated twice with BNT162b2 or mRNA-1273. B-cell subsets were analyzed prior to vaccination. Two independent anti-SARS-CoV-2 S immunoassays targeting the receptor-binding domain (RBD) or trimeric S protein (TSP) were performed three to four weeks after the second vaccination.

Results Seroconversion occurred in 100% of the healthy controls, in contrast to 67% (RBD) and 82% (TSP) of the patients, while only 32% (RBD) and 22% (TSP) achieved antibody levels comparable to those of healthy controls. The number of circulating naïve B cell was strongly associated with antibody levels (r=0.761, P<0.001) across all immunosuppressive treatments or conditions. In multivariable analysis, the number of naïve B cells was an independent predictor for achieving antibody levels comparable to healthy controls, and receiver operating characteristic analysis predicted that at least six naïve B cells per µL were required.

Conclusions Assessing the abundance of naïve B cells in immunocompromised patients could be useful in predicting the optimal vaccination response.

What is already known about this subject?

  • ▸ Humoral vaccination response is impaired in patients with immunodeficiency or B-cell-depleting therapies, such as anti-CD20 antibody therapy or hematopoietic stem cell transplantation.

  • ▸ Current recommendations advise an interval of six months between the most recent anti-CD20 antibody administration and vaccination.

What does this study add?

  • ▸ Immunocompromised patients can achieve anti-spike protein antibody levels similar to those in healthy subjects after vaccination.

  • ▸ Independent of concurrent immunosuppressive treatment or condition, the number of naïve B cells, but not the total number of B cells, is strongly associated with anti-spike protein antibody levels, similar to that in healthy subjects.

How might this impact on clinical practice or future developments?

  • ▸ Assessment of the abundance of naïve B cells in immunocompromised patients could be used to schedule vaccinations for optimal antibody responses.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT04858607

Funding Statement

no external funding was received

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethikkomission der Medizinischen Universitaet Graz

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data will be shared upon request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted August 13, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Association of Naïve B Cells with Humoral Response to SARS-CoV-2 Vaccination
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Association of Naïve B Cells with Humoral Response to SARS-CoV-2 Vaccination
Eduard Schulz, Isabel Hodl, Patrick Forstner, Stefan Hatzl, Nazanin Sareban, Martina Moritz, Johannes Fessler, Barbara Dreo, Barbara Uhl, Claudia Url, Andrea Grisold, Michael Khalil, Barbara Kleinhappl, Christian Enzinger, Martin H. Stradner, Hildegard Greinix, Peter Schlenke, Ivo Steinmetz
medRxiv 2021.08.11.21261898; doi: https://doi.org/10.1101/2021.08.11.21261898
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Association of Naïve B Cells with Humoral Response to SARS-CoV-2 Vaccination
Eduard Schulz, Isabel Hodl, Patrick Forstner, Stefan Hatzl, Nazanin Sareban, Martina Moritz, Johannes Fessler, Barbara Dreo, Barbara Uhl, Claudia Url, Andrea Grisold, Michael Khalil, Barbara Kleinhappl, Christian Enzinger, Martin H. Stradner, Hildegard Greinix, Peter Schlenke, Ivo Steinmetz
medRxiv 2021.08.11.21261898; doi: https://doi.org/10.1101/2021.08.11.21261898

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Rheumatology
  • Hematology
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1101)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (502)
  • Epidemiology (9782)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2318)
  • Geriatric Medicine (223)
  • Health Economics (463)
  • Health Informatics (1563)
  • Health Policy (737)
  • Health Systems and Quality Improvement (606)
  • Hematology (238)
  • HIV/AIDS (507)
  • Infectious Diseases (except HIV/AIDS) (11656)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (240)
  • Medical Ethics (67)
  • Nephrology (258)
  • Neurology (2148)
  • Nursing (134)
  • Nutrition (338)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (518)
  • Oncology (1183)
  • Ophthalmology (366)
  • Orthopedics (129)
  • Otolaryngology (220)
  • Pain Medicine (148)
  • Palliative Medicine (50)
  • Pathology (313)
  • Pediatrics (698)
  • Pharmacology and Therapeutics (302)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2188)
  • Public and Global Health (4673)
  • Radiology and Imaging (781)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (624)
  • Rheumatology (274)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (210)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)